GlassScriptPhysician profile
Lindsey J Davison
NPI 1962839357
$3,216.44
in general payments reported to CMS, 2019-2025
18 companies · $596 in 2025
The $596 reported for 2025 was more than what 90% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $557 · 2022: $596 · 2023: $757 · 2024: $711 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $889.19 | 2021-2025 | |
| Pfizer INC. | $376.98 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $365.40 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $339.70 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $228.67 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $223.33 | 2023-2025 | Zurzuvae |
| Myovant Sciences INC. | $193.18 | 2021-2022 | |
| Exeltis, USA INC. | $163.16 | 2023-2025 | Slynd, Nuvessa |
| Shield Therapeutics INC | $78.74 | 2023-2025 | Accrufer |
| Evofem Biosciences, INC. | $71.96 | 2022-2024 | Phexxi |
| Vertex Pharmaceuticals Incorporated | $69.90 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.13 | 2024-2025 | |
| Therapeuticsmd, INC. | $39.14 | 2021-2022 | |
| Baxter Healthcare | $38.68 | 2024 | Perclot |
| Organon LLC | $36.27 | 2022-2023 | Nexplanon |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $19.97 | 2023 | Exparel |
| Hologic Sales and Service, LLC | $17.87 | 2022 | |
| Avion Pharmaceuticals | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Davison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.